Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Change in Cash (2016 - 2025)

Historic Change in Cash for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to $594339.0.

  • Outlook Therapeutics' Change in Cash rose 10644.27% to $594339.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $3.0 million, marking a year-over-year increase of 13696.9%. This contributed to the annual value of -$6.8 million for FY2025, which is 1913.88% up from last year.
  • As of Q4 2025, Outlook Therapeutics' Change in Cash stood at $594339.0, which was up 10644.27% from -$817729.0 recorded in Q3 2025.
  • Outlook Therapeutics' Change in Cash's 5-year high stood at $1.9 million during Q1 2025, with a 5-year trough of -$9.2 million in Q4 2024.